PUBLISHER: MarketLine | PRODUCT CODE: 1125539
PUBLISHER: MarketLine | PRODUCT CODE: 1125539
The Emerging 5 Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2017-21, and forecast to 2026). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
These countries contributed $112,996.1 million to the global generics industry in 2021, with a compound annual growth rate (CAGR) of 7.3% between 2007 and 2011. The top 5 emerging countries are expected to reach a value of $142,172.4 million in 2026, with a CAGR of 4.7% over the 2021-26 period.
Within the generics industry, China is the leading country among the top 5 emerging nations, with market revenues of $85,327.0 million in 2021. This was followed by India and Mexico with a value of $17,283.5 and $6,849.9 million, respectively.
China is expected to lead the generics industry in the top five emerging nations, with a value of $102,263.8 million in 2026, followed by India and Mexico with expected values of $26,692.2 and $8,504.7 million, respectively.